Early Enteral Nutrition Does Not Cause Excessive Inflammatory Response in Veno-Arterial Extracorporeal Membrane Oxygenation Patients
DOI:
https://doi.org/10.59958/hsf.7417Keywords:
veno-arterial extracorporeal membrane oxygenation, enteral nutrition, inflammatory cytokine, gastrointestinal hormoneAbstract
Background: To evaluate the safety between early enteral nutrition (EN) and parenteral nutrition (PN) by observing changes in inflammatory cytokines and gastrointestinal hormones in veno-arterial extracorporeal membrane oxygenation (VA ECMO) patients. Methods: This study was a prospective, observational study that enrolled patients receiving VA ECMO treatment from 1 January 2020 to 31 December 2023. Patients were enrolled in an EN group or a PN group according to the inclusion criteria. The concentration of interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor α (TNF-α) on the first five days of VA ECMO treatement were tested in both groups. Serum concentrations of Motilin (MOT), Gastrin (GAS), Cholecystokinin (CCK), and Calcitonin gene-related peptide (CGRP) were measured for the EN group. Student t test or Fisher test was used to compare the difference between the two groups. Results: 28 patients were enrolled in this study; 16 in the EN group and 12 in the PN group. The baseline characteristics were comparable between the two groups. The concentration of IL-1β in the EN group was significantly lower than that of the PN group on day 3 and day 4 (day 3: 0.65 ± 0.17 pg/mL vs. 0.93 ± 0.09 pg/mL, p < 0.01, day 4: 0.52 ± 0.16 pg/mL vs. 0.74 ± 0.12 pg/mL, p < 0.01). The concentration of IL-6 and TNF-α in the EN group were also significantly lower than in the PN group on day 3 and day 4. There was no statistical difference in IL-10 serum concentration between the EN group and the PN group from day 1 to day 5. On day 3, the concentration of MOT, GAS and CCK reached the highest level and then gradually decreased. Conclusions: Implementation of early EN in patients receiving VA ECMO does not cause significant elevation of pro-inflammatory cytokines with an excessive inflammatory response.
References
Goris RJ. MODS/SIRS: result of an overwhelming inflammatory response? World Journal of Surgery. 1996; 20: 418–421.
Gosling P. The cellular, immune, and metabolic response to trauma. Critical Reviews in Clinical Laboratory Sciences. 1998; 35: 59–112.
McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN. Journal of Parenteral and Enteral Nutrition. 2016; 40: 159–211.
Yang X, Li R, Zhai J, Fan Y, Gong S, Li L, et al. Effects of early enteral nutrition in patients with severe burns: A systematic review. Medicine. 2024; 103: e37023.
Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO Journal (American Society for Artificial Internal Organs: 1992). 1999; 45: 250–263.
Ren JA, Mao Y, Wang GF, Wang XB, Fan CG, Wang ZM, et al. Enteral refeeding syndrome after long-term total parenteral nutrition. Chinese Medical Journal. 2006; 119: 1856–1860.
Anup R, Susama P, Balasubramanian KA. Role of xanthine oxidase in small bowel mucosal dysfunction after surgical stress. The British Journal of Surgery. 2000; 87: 1094–1101.
Hatami S, Hefler J, Freed DH. Inflammation and Oxidative Stress in the Context of Extracorporeal Cardiac and Pulmonary Support. Frontiers in Immunology. 2022; 13: 831930.
Olmos G, Lladó J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators of Inflammation. 2014; 2014: 861231.
Zhai LP, Liu CY, Wang L. Effects of early enteral nutrition support on inflammatory factors and gastric mucosa in patients with craniocerebral trauma. Chongqing Medicine. 2014; 15: 1912–1914. (In Chinese)
Li P, Jian JN, Chen RL. Effect of Early Enteral Nutrition on Serum Inflammatory Factors and Intestinal Mucosal Permeability in Patients with Severe Acute Pancreatitis. The Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology. 2021; 32: 907–912.
Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annual Review of Immunology. 2009; 27: 519–550.
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta. 2011; 1813: 878–888.
Dinarello CA, van der Meer JWM. Treating inflammation by blocking interleukin-1 in humans. Seminars in Immunology. 2013; 25: 469–484.
Hazlett LD, Jiang X, McClellan SA. IL-10 function, regulation, and in bacterial keratitis. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics. 2014; 30: 373–380.
Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology. 2011; 29: 71–109.
Saraiva M, Vieira P, O'Garra A. Biology and therapeutic potential of interleukin-10. The Journal of Experimental Medicine. 2020; 217: e20190418.
Johnson LR, Lichtenberger LM, Copeland EM, Dudrick SJ, Castro GA. Action of gastrin on gastrointestinal structure and function. Gastroenterology. 1975; 68: 1184–1192.
Shulman DI, Kanarek K. Gastrin, motilin, insulin, and insulin-like growth factor-I concentrations in very-low-birth-weight infants receiving enteral or parenteral nutrition. JPEN. Journal of Parenteral and Enteral Nutrition. 1993; 17: 130–133.
Hanekamp MN, Spoel M, Sharman-Koendjbiharie M, Hop WC, Hopman WP, Jansen JB, et al. Gut hormone profiles in critically ill neonates on extracorporeal membrane oxygenation. Journal of Pediatric Gastroenterology and Nutrition. 2005; 40: 175–179.
Brown JC, Cook MA, Dryburgh JR. Motilin, a gastric motor activity stimulating polypeptide: the complete amino acid sequence. Canadian Journal of Biochemistry. 1973; 51: 533–537.
Nguyen NQ, Fraser RJ, Chapman MJ, Bryant LK, Holloway RH, Vozzo R, et al. Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrations. Critical Care Medicine. 2007; 35: 82–88.
Luyer MD, Greve JWM, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. The Journal of Experimental Medicine. 2005; 202: 1023–1029.
Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiological Reviews. 2014; 94: 1099–1142.
